Drug prices

New gene therapy has $1.8 million price tag

The price of Zynteglo, a new gene therapy made by Bluebird Bio to treat a rare genetic blood disorder, will be almost €1.6 million ($1.8 million) in Europe, the company said Friday.

What's happening: Bluebird expects to get FDA approval for Zynteglo next year and to price it similarly in the U.S., Reuters reports.

Drugmakers sue to block rule requiring drug prices in TV ads

A street sign in front of a building near Amgen headquarters
Amgen is one of 3 drugmakers suing the Trump administration. Photo: Al Seib/Los Angeles Times via Getty Images

Amgen, Eli Lilly, Merck and the Association of National Advertisers are suing the Trump administration over its rule forcing pharmaceutical companies to display drugs' list prices in TV commercials. They say the rule violates the First Amendment and exceeds the government's authority.

The big picture: Experts expected drugmakers to file such a lawsuit — even though the new regulation isn't expected to actually affect drug pricing.